Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.

Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker than those infected with ...

Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...

New research reveals that even mild respiratory infections can leave lasting biological changes. However, COVID-19 stands ...

A single-dose multicomponent mRNA vaccine elicits durable immune responses against influenza and COVID-19 in a Phase 1/2 trial.

A rare clotting disorder puzzled doctors during the COVID vaccine rollout. New research reveals the unlikely chain of events ...

Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable ...

Six years after the start of the COVID-19 pandemic, millions of Americans are still living with its long-term effects.

Vaccines have traditionally worked by teaching the immune system to recognize a specific virus or bacterium—in effect, ...

The updated formula for Moderna’s COVID-19 vaccine generates a 16-fold increase in antibodies that neutralize the intended SARS-CoV-2 variant target among recipients, according to a press release from ...